SCPS (OTC)
SCOPUS BIOPHARMA INC
$0.000600
+0.000000 (+0.00%)
Prev close: $0.000600
Company Information
- Exchange
- OTC Link
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Morris C. Laster, MD
- Asset Type
- otc
- Website
- —
Fundamentals
- Market Cap
- $0.03M
- Employees
- 13
- P/E (TTM)
- —
- P/B (TTM)
- —
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
2
Strong Buy
4
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Sep 2021 (Q3)
|
$-0.08 | $-0.23 | +0.1546 | +65.90% |
|
Jun 2021 (Q2)
|
$-0.97 | $-0.23 | -0.7354 | -313.47% |
|
Mar 2021 (Q1)
|
$-0.22 | $-0.08 | -0.1384 | -169.61% |
|
Dec 2020 (Q4)
|
$-0.06 | $-0.09 | +0.0318 | +34.64% |
Financial Statements
| Operating Expenses | $9.34M |
| Research and Development | $5.27M |
| Other Operating Expenses | $4.08M |
| Income/Loss From Continuing Operations After Tax | -$9.34M |
| Income/Loss From Continuing Operations Before Tax | -$5.22M |
| Net Income/Loss | -$9.34M |
| Net Income/Loss Attributable To Noncontrolling Interest | -$647.19K |
| Net Income/Loss Attributable To Parent | -$8.70M |
| Net Income/Loss Available To Common Stockholders, Basic | -$8.70M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.31 |
| Diluted Earnings Per Share | -$0.31 |
| Basic Average Shares | 56,176,207 |
| Diluted Average Shares | 56,176,207 |
| Assets | $497.55K |
| Current Assets | $495.85K |
| Noncurrent Assets | $1.70K |
| Fixed Assets | $1.70K |
| Liabilities | $11.00M |
| Current Liabilities | $11.00M |
| Noncurrent Liabilities | $0.00 |
| Equity | -$10.50M |
| Equity Attributable To Noncontrolling Interest | -$1.05M |
| Equity Attributable To Parent | -$9.45M |
| Liabilities And Equity | $497.55K |
| Net Cash Flow From Operating Activities | -$3.04M |
| Net Cash Flow From Operating Activities, Continuing | -$3.04M |
| Net Cash Flow From Financing Activities | $2.22M |
| Net Cash Flow | $6.85M |
| Net Cash Flow, Continuing | $6.85M |
| Comprehensive Income/Loss | -$8.65M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$8.65M |
| Other Comprehensive Income/Loss | -$1.21M |